Article Details

Verismo Therapeutics' Trial for CAR-T SynKIR-310 Doses First Patient With Follicular Lymphoma

Retrieved on: 2025-10-11 12:27:19

Tags for this article:

Click the tags to see associated articles and topics

Verismo Therapeutics' Trial for CAR-T SynKIR-310 Doses First Patient With Follicular Lymphoma. View article details on hiswai:

Excerpt

SimulatEd™: Patient-Centered Care to Improve Outcomes in Chronic Lymphocytic Leukemia. Case-based Simulation. SimulatEd™: Patient-Centered Care ...

Article found on: www.cgtlive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo